Investor Overview

Company Profile

DiaMedica Therapeutics Inc. is a clinical stage biopharmaceutical company focused on developing novel treatments for chronic kidney disease and acute ischemic stroke. DiaMedica's shares are listed on The Nasdaq Capital Market under the trading symbol "DMAC."

-

Nasdaq Stock Snapshot

DMAC Symbol
Nasdaq Market
-- Volume
-- Price
-- Change
Go to Detailed Stock Information ›

Upcoming Events

31st Annual Roth Annual Conference

View IR Calendar ›